533 related articles for article (PubMed ID: 25401298)
1. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
Muona M; Berkovic SF; Dibbens LM; Oliver KL; Maljevic S; Bayly MA; Joensuu T; Canafoglia L; Franceschetti S; Michelucci R; Markkinen S; Heron SE; Hildebrand MS; Andermann E; Andermann F; Gambardella A; Tinuper P; Licchetta L; Scheffer IE; Criscuolo C; Filla A; Ferlazzo E; Ahmad J; Ahmad A; Baykan B; Said E; Topcu M; Riguzzi P; King MD; Ozkara C; Andrade DM; Engelsen BA; Crespel A; Lindenau M; Lohmann E; Saletti V; Massano J; Privitera M; Espay AJ; Kauffmann B; Duchowny M; Møller RS; Straussberg R; Afawi Z; Ben-Zeev B; Samocha KE; Daly MJ; Petrou S; Lerche H; Palotie A; Lehesjoki AE
Nat Genet; 2015 Jan; 47(1):39-46. PubMed ID: 25401298
[TBL] [Abstract][Full Text] [Related]
2. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
Nascimento FA; Andrade DM
Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
[TBL] [Abstract][Full Text] [Related]
3. Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutation.
Kim H; Lee S; Choi M; Kim H; Hwang H; Choi J; Chae JH; Kim KJ; Lim BC
Brain Dev; 2018 May; 40(5):429-432. PubMed ID: 29428275
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological rescue of mutated K
Munch AS; Saljic A; Boddum K; Grunnet M; Hougaard C; Jespersen T
Eur J Pharmacol; 2018 Aug; 833():255-262. PubMed ID: 29894724
[TBL] [Abstract][Full Text] [Related]
5. KCNC1-related disorders: new de novo variants expand the phenotypic spectrum.
Park J; Koko M; Hedrich UBS; Hermann A; Cremer K; Haberlandt E; Grimmel M; Alhaddad B; Beck-Woedl S; Harrer M; Karall D; Kingelhoefer L; Tzschach A; Matthies LC; Strom TM; Ringelstein EB; Sturm M; Engels H; Wolff M; Lerche H; Haack TB
Ann Clin Transl Neurol; 2019 Jul; 6(7):1319-1326. PubMed ID: 31353862
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenic gene variants and clinical phenotype features of 26 children with progressive myoclonic epilepsy].
Zhang J; Zhang YH; Chen JY; Ji TY; Yang ZX; Yang XL; Sun W; Zhang LP; Wu XR
Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):458-464. PubMed ID: 31216804
[No Abstract] [Full Text] [Related]
7. Progressive myoclonus epilepsy KCNC1 variant causes a developmental dendritopathy.
Carpenter JC; Männikkö R; Heffner C; Heneine J; Sampedro-Castañeda M; Lignani G; Schorge S
Epilepsia; 2021 May; 62(5):1256-1267. PubMed ID: 33735526
[TBL] [Abstract][Full Text] [Related]
8. Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations.
Cameron JM; Maljevic S; Nair U; Aung YH; Cogné B; Bézieau S; Blair E; Isidor B; Zweier C; Reis A; Koenig MK; Maarup T; Sarco D; Afenjar A; Huq AHMM; Kukolich M; Billette de Villemeur T; Nava C; Héron B; Petrou S; Berkovic SF
Ann Clin Transl Neurol; 2019 Jul; 6(7):1263-1272. PubMed ID: 31353855
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy.
Feng H; Clatot J; Kaneko K; Flores-Mendez M; Wengert ER; Koutcher C; Hoddeson E; Lopez E; Lee D; Arias L; Liang Q; Zhang X; Somarowthu A; Covarrubias M; Gunthorpe MJ; Large CH; Akizu N; Goldberg EM
Cell Rep Med; 2024 Feb; 5(2):101389. PubMed ID: 38266642
[TBL] [Abstract][Full Text] [Related]
10. Loss of Function of KCNC1 is associated with intellectual disability without seizures.
Poirier K; Viot G; Lombardi L; Jauny C; Billuart P; Bienvenu T
Eur J Hum Genet; 2017 May; 25(5):560-564. PubMed ID: 28145425
[TBL] [Abstract][Full Text] [Related]
11. Progressive myoclonic epilepsy: myoclonic epilepsy and ataxia due to KCNC1 mutation (MEAK): a case report and review of the literature.
Barot N; Margiotta M; Nei M; Skidmore C
Epileptic Disord; 2020 Oct; 22(5):654-658. PubMed ID: 32972906
[TBL] [Abstract][Full Text] [Related]
12. A KCNC1-related neurological disorder due to gain of Kv3.1 function.
Clatot J; Ginn N; Costain G; Goldberg EM
Ann Clin Transl Neurol; 2023 Jan; 10(1):111-117. PubMed ID: 36419348
[TBL] [Abstract][Full Text] [Related]
13. Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes.
Courage C; Oliver KL; Park EJ; Cameron JM; Grabińska KA; Muona M; Canafoglia L; Gambardella A; Said E; Afawi Z; Baykan B; Brandt C; di Bonaventura C; Chew HB; Criscuolo C; Dibbens LM; Castellotti B; Riguzzi P; Labate A; Filla A; Giallonardo AT; Berecki G; Jackson CB; Joensuu T; Damiano JA; Kivity S; Korczyn A; Palotie A; Striano P; Uccellini D; Giuliano L; Andermann E; Scheffer IE; Michelucci R; Bahlo M; Franceschetti S; Sessa WC; Berkovic SF; Lehesjoki AE
Am J Hum Genet; 2021 Apr; 108(4):722-738. PubMed ID: 33798445
[TBL] [Abstract][Full Text] [Related]
14. Myoclonus improvement after seizures in progressive myoclonic epilepsy type 7: a case report.
G S B Lima PL; Nobrega PR; Freua F; Braga-Neto P; Paiva ARB; Guimarães TG; Kok F
BMC Neurol; 2024 May; 24(1):169. PubMed ID: 38783211
[TBL] [Abstract][Full Text] [Related]
15. Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K
Oliver KL; Franceschetti S; Milligan CJ; Muona M; Mandelstam SA; Canafoglia L; Boguszewska-Chachulska AM; Korczyn AD; Bisulli F; Di Bonaventura C; Ragona F; Michelucci R; Ben-Zeev B; Straussberg R; Panzica F; Massano J; Friedman D; Crespel A; Engelsen BA; Andermann F; Andermann E; Spodar K; Lasek-Bal A; Riguzzi P; Pasini E; Tinuper P; Licchetta L; Gardella E; Lindenau M; Wulf A; Møller RS; Benninger F; Afawi Z; Rubboli G; Reid CA; Maljevic S; Lerche H; Lehesjoki AE; Petrou S; Berkovic SF
Ann Neurol; 2017 May; 81(5):677-689. PubMed ID: 28380698
[TBL] [Abstract][Full Text] [Related]
16. A KCNC1 mutation in epilepsy of infancy with focal migrating seizures produces functional channels that fail to be regulated by PKC phosphorylation.
Zhang Y; Ali SR; Nabbout R; Barcia G; Kaczmarek LK
J Neurophysiol; 2021 Aug; 126(2):532-539. PubMed ID: 34232791
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia.
Corbett MA; Schwake M; Bahlo M; Dibbens LM; Lin M; Gandolfo LC; Vears DF; O'Sullivan JD; Robertson T; Bayly MA; Gardner AE; Vlaar AM; Korenke GC; Bloem BR; de Coo IF; Verhagen JM; Lehesjoki AE; Gecz J; Berkovic SF
Am J Hum Genet; 2011 May; 88(5):657-63. PubMed ID: 21549339
[TBL] [Abstract][Full Text] [Related]
18. Molecular background of progressive myoclonus epilepsy.
Lehesjoki AE
EMBO J; 2003 Jul; 22(14):3473-8. PubMed ID: 12853462
[TBL] [Abstract][Full Text] [Related]
19. Mutations in NHLRC1 cause progressive myoclonus epilepsy.
Chan EM; Young EJ; Ianzano L; Munteanu I; Zhao X; Christopoulos CC; Avanzini G; Elia M; Ackerley CA; Jovic NJ; Bohlega S; Andermann E; Rouleau GA; Delgado-Escueta AV; Minassian BA; Scherer SW
Nat Genet; 2003 Oct; 35(2):125-7. PubMed ID: 12958597
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene.
Kousi M; Anttila V; Schulz A; Calafato S; Jakkula E; Riesch E; Myllykangas L; Kalimo H; Topçu M; Gökben S; Alehan F; Lemke JR; Alber M; Palotie A; Kopra O; Lehesjoki AE
J Med Genet; 2012 Jun; 49(6):391-9. PubMed ID: 22693283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
